Watchlist Manager

Watchlist

Price: 7.84 CNY -0.88% Market Closed

Market Cap: ¥10.7B

T	Tecon Biology Co Ltd SZSE:002100	CN
	Novocure Ltd NASDAQ:NVCR	JE

Income Statement

Currency: CNY

	Dec-2006	Mar-2007	Jun-2007	Sep-2007	Dec-2007	Mar-2008	Jun-2008	Sep-2008	Dec-2008	Mar-2009	Jun-2009	Sep-2009	Dec-2009	Mar-2010	Jun-2010	Sep-2010	Dec-2010	Mar-2011	Jun-2011	Sep-2011	Dec-2011	Mar-2012	Jun-2012	Sep-2012	Dec-2012	Mar-2013	Jun-2013	Sep-2013	Dec-2013	Mar-2014	Jun-2014	Sep-2014	Dec-2014	Mar-2015	Jun-2015	Sep-2015	Dec-2015	Mar-2016	Jun-2016	Sep-2016	Dec-2016	Mar-2017	Jun-2017	Sep-2017	Dec-2017	Mar-2018	Jun-2018	Sep-2018	Dec-2018	Mar-2019	Jun-2019	Sep-2019	Dec-2019	Mar-2020	Jun-2020	Sep-2020	Dec-2020	Mar-2021	Jun-2021	Sep-2021	Dec-2021	Mar-2022	Jun-2022	Sep-2022	Dec-2022	Mar-2023	Jun-2023	Sep-2023	Dec-2023	Mar-2024	Jun-2024	Sep-2024	Dec-2024	Mar-2025	Jun-2025	Sep-2025
Revenue
Interest Expense	11	0	0	0	10	0	0	0	20	0	0	0	23	0	0	0	38	0	0	0	58	0	0	0	42	0	0	0	28	0	0	0	45	0	0	0	43	0	0	0	25	0	0	11	30	0	0	24	86	106	153	182	193	203	203	191	196	198	197	220	206	212	244	232	249	254	0	192	246	153	202	184	179	172	0	0
Revenue	422 N/A	441 +4%	476 +8%	597 +26%	671 +12%	737 +10%	864 +17%	921 +7%	1 068 +16%	1 299 +22%	1 549 +19%	1 918 +24%	2 075 +8%	2 174 +5%	2 236 +3%	2 243 +0%	2 369 +6%	2 425 +2%	2 550 +5%	2 731 +7%	2 984 +9%	3 109 +4%	3 343 +8%	3 486 +4%	3 327 -5%	3 489 +5%	3 437 -2%	3 470 +1%	3 725 +7%	3 638 -2%	3 823 +5%	3 978 +4%	4 236 +6%	4 492 +6%	4 635 +3%	4 542 -2%	4 167 -8%	4 252 +2%	4 260 +0%	4 268 +0%	4 444 +4%	4 521 +2%	4 550 +1%	4 654 +2%	4 630 -1%	4 587 -1%	4 647 +1%	4 875 +5%	5 273 +8%	5 481 +4%	5 701 +4%	6 742 +18%	7 476 +11%	8 255 +10%	9 465 +15%	10 917 +15%	11 987 +10%	13 343 +11%	15 200 +14%	15 695 +3%	15 711 +0%	15 797 +1%	15 836 +0%	16 301 +3%	16 989 +4%	17 231 +1%	17 686 +3%	18 552 +5%	19 026 +3%	18 912 -1%	18 056 -5%	17 407 -4%	17 176 -1%	17 579 +2%	18 029 +3%	17 699 -2%
Gross Profit
Cost of Revenue	(332)	(345)	(369)	(477)	(520)	(577)	(688)	(731)	(838)	(1 038)	(1 261)	(1 590)	(1 726)	(1 819)	(1 866)	(1 869)	(1 967)	(1 998)	(2 103)	(2 273)	(2 537)	(2 661)	(2 881)	(3 013)	(2 812)	(2 941)	(2 885)	(2 886)	(3 097)	(3 007)	(3 117)	(3 199)	(3 364)	(3 549)	(3 643)	(3 568)	(3 259)	(3 294)	(3 292)	(3 195)	(3 354)	(3 441)	(3 488)	(3 606)	(3 547)	(3 554)	(3 633)	(3 815)	(4 163)	(4 381)	(4 526)	(5 362)	(5 600)	(6 008)	(6 633)	(7 454)	(8 272)	(9 508)	(11 597)	(13 186)	(14 593)	(14 823)	(15 224)	(15 070)	(15 373)	(15 423)	(16 229)	(17 494)	(18 961)	(18 276)	(16 918)	(15 932)	(15 101)	(15 516)	(15 845)	(15 751)
Gross Profit	90 N/A	96 +7%	107 +12%	120 +12%	150 +25%	160 +7%	176 +10%	191 +8%	230 +21%	261 +14%	288 +10%	328 +14%	349 +6%	354 +2%	370 +4%	374 +1%	402 +8%	427 +6%	447 +5%	458 +2%	447 -2%	448 +0%	463 +3%	473 +2%	516 +9%	549 +6%	551 +0%	584 +6%	627 +7%	631 +1%	706 +12%	779 +10%	872 +12%	944 +8%	993 +5%	974 -2%	909 -7%	958 +5%	969 +1%	1 073 +11%	1 090 +2%	1 080 -1%	1 062 -2%	1 048 -1%	1 083 +3%	1 033 -5%	1 014 -2%	1 060 +5%	1 110 +5%	1 100 -1%	1 175 +7%	1 381 +17%	1 876 +36%	2 247 +20%	2 833 +26%	3 463 +22%	3 715 +7%	3 835 +3%	3 603 -6%	2 509 -30%	1 118 -55%	974 -13%	613 -37%	1 231 +101%	1 616 +31%	1 808 +12%	1 457 -19%	1 059 -27%	65 -94%	636 +876%	1 138 +79%	1 475 +30%	2 075 +41%	2 063 -1%	2 185 +6%	1 948 -11%
Operating Income
Operating Expenses	(38)	(44)	(56)	(68)	(90)	(103)	(113)	(116)	(128)	(146)	(163)	(179)	(216)	(215)	(213)	(224)	(246)	(259)	(286)	(294)	(281)	(325)	(341)	(362)	(373)	(404)	(414)	(437)	(437)	(450)	(496)	(550)	(599)	(688)	(733)	(705)	(655)	(687)	(653)	(688)	(683)	(658)	(671)	(656)	(625)	(624)	(612)	(628)	(711)	(713)	(790)	(923)	(1 120)	(1 140)	(1 244)	(1 377)	(1 699)	(1 851)	(2 072)	(2 075)	(1 539)	(1 783)	(1 489)	(1 350)	(1 174)	(1 209)	(1 320)	(1 343)	(1 320)	(1 833)	(1 628)	(1 648)	(1 293)	(1 210)	(1 314)	(1 253)
Selling, General & Administrative	(38)	(41)	(53)	(65)	(89)	(97)	(106)	(108)	(126)	(145)	(161)	(176)	(216)	(216)	(208)	(217)	(245)	(258)	(280)	(295)	(280)	(279)	(308)	(332)	(351)	(388)	(393)	(410)	(407)	(428)	(465)	(524)	(560)	(650)	(698)	(661)	(617)	(639)	(612)	(639)	(642)	(639)	(640)	(631)	(599)	(629)	(636)	(652)	(619)	(633)	(672)	(795)	(1 009)	(1 055)	(1 161)	(1 263)	(1 595)	(1 763)	(1 931)	(1 948)	(1 353)	(1 293)	(1 108)	(963)	(1 005)	(960)	(969)	(971)	(1 069)	(1 141)	(1 050)	(1 047)	(1 014)	(1 074)	(1 092)	(1 072)
Research & Development	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(64)	(91)	(127)	(137)	(69)	(94)	(95)	(129)	(78)	(108)	(109)	(105)	(136)	(155)	(158)	(162)	(131)	(183)	(201)	(237)	(212)	(284)	(313)	(329)	(150)	(233)	(208)	(165)
Depreciation & Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(19)	0	0	0	(25)	0	0	0	(33)	0	0	0	(33)	0	0	0	(36)	0	0	0	(33)	0	0	0	(37)	0	0	0	(52)	0	0	0	(66)	0	0	0	(82)	0	0	0	(101)	0	0	0	(105)	0	0	0	(178)	0	0	0
Other Operating Expenses	0	(3)	(3)	(3)	0	(6)	(7)	(8)	(2)	(1)	(3)	(3)	0	1	(6)	(7)	(1)	(1)	(6)	1	(1)	(46)	(33)	(31)	(3)	(17)	(21)	(28)	(4)	(23)	(31)	(26)	(6)	(38)	(35)	(45)	(5)	(48)	(41)	(49)	(5)	(19)	(32)	(25)	6	5	25	24	10	12	9	10	11	10	11	15	40	20	(32)	(22)	32	(336)	(223)	(225)	64	(66)	(150)	(136)	65	(408)	(266)	(272)	48	98	(14)	(16)
Operating Income	52 N/A	52 N/A	51 -2%	51 +0%	61 +19%	57 -7%	62 +10%	74 +19%	102 +37%	116 +14%	125 +8%	149 +20%	133 -11%	139 +5%	156 +13%	150 -4%	156 +4%	168 +7%	161 -4%	163 +1%	166 +2%	123 -26%	121 -2%	111 -9%	143 +29%	144 +1%	138 -5%	147 +7%	191 +30%	181 -5%	210 +16%	229 +9%	274 +20%	256 -7%	260 +2%	269 +4%	253 -6%	272 +7%	315 +16%	386 +22%	407 +6%	422 +4%	391 -7%	392 +0%	458 +17%	409 -11%	402 -2%	432 +8%	399 -8%	388 -3%	385 -1%	458 +19%	757 +65%	1 107 +46%	1 589 +44%	2 086 +31%	2 016 -3%	1 983 -2%	1 531 -23%	433 -72%	(421) N/A	(809) -92%	(876) -8%	(119) +86%	443 N/A	599 +35%	137 -77%	(285) N/A	(1 255) -341%	(1 197) +5%	(490) +59%	(173) +65%	782 N/A	853 +9%	870 +2%	695 -20%
Pre-Tax Income
Interest Income Expense	(11)	(10)	(10)	(8)	(9)	(9)	(11)	(15)	(18)	(22)	(23)	(22)	(24)	(31)	(43)	(42)	(44)	(46)	(41)	(40)	(37)	(33)	(31)	(33)	(23)	(17)	(15)	(6)	0	(8)	(9)	(29)	(30)	(35)	(2)	7	(37)	14	(15)	(10)	(20)	(21)	(26)	(30)	(26)	(36)	(38)	(45)	(66)	(92)	(124)	(152)	(150)	(169)	(161)	(140)	(148)	(127)	(141)	(153)	(162)	(178)	(185)	(191)	(186)	(192)	(190)	(198)	(185)	(176)	(166)	(152)	(143)	(161)	(156)	(151)
Non-Reccuring Items	(3)	0	0	0	(5)	0	0	0	(1)	0	0	0	(3)	0	0	0	2	0	0	0	(48)	0	0	0	0	0	0	0	(18)	0	0	0	(20)	0	0	0	24	0	0	0	(6)	(8)	(12)	(14)	(6)	(7)	(3)	(3)	0	(14)	(15)	(14)	(16)	(20)	(32)	(45)	(60)	(56)	(57)	(50)	(33)	(27)	(11)	(5)	(37)	(32)	(35)	(23)	(39)	7	10	0	(36)	3	3	2
Gain/Loss on Disposition of Assets	0	0	0	0	(1)	0	0	0	(1)	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	(1)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income	0	(0)	(1)	(1)	2	4	5	5	6	4	4	4	6	6	6	11	9	11	12	9	10	10	10	12	13	17	15	13	9	6	14	19	36	42	46	49	30	30	21	14	45	45	56	57	3	3	(11)	(14)	1	1	1	(0)	(1)	(4)	(1)	0	0	2	(13)	(21)	(47)	(56)	(55)	(56)	(3)	(38)	(35)	(44)	(14)	(53)	(54)	(29)	7	10	20	9
Pre-Tax Income	38 N/A	41 +9%	40 -3%	43 +5%	49 +15%	53 +7%	56 +7%	65 +15%	88 +36%	97 +11%	106 +8%	131 +24%	112 -15%	114 +2%	120 +5%	119 -1%	126 +6%	132 +5%	132 N/A	132 0%	91 -31%	100 +10%	101 +1%	90 -10%	134 +49%	144 +8%	138 -4%	154 +11%	182 +19%	180 -1%	216 +20%	219 +1%	259 +18%	262 +1%	304 +16%	325 +7%	270 -17%	315 +17%	321 +2%	389 +21%	426 +9%	438 +3%	408 -7%	405 -1%	429 +6%	370 -14%	350 -5%	370 +6%	334 -10%	283 -15%	247 -13%	291 +18%	590 +102%	915 +55%	1 395 +53%	1 902 +36%	1 808 -5%	1 803 0%	1 320 -27%	210 -84%	(663) N/A	(1 070) -61%	(1 126) -5%	(371) +67%	216 N/A	338 +56%	(124) N/A	(549) -344%	(1 493) -172%	(1 419) +5%	(701) +51%	(354) +50%	611 N/A	705 +15%	738 +5%	554 -25%
Net Income
Tax Provision	0	0	0	0	0	(0)	(6)	(13)	(17)	(23)	(16)	(15)	(13)	(13)	(20)	(19)	(18)	(17)	(19)	(23)	(14)	(14)	(13)	(9)	(30)	(30)	(25)	(25)	(17)	(18)	(19)	(23)	(29)	(32)	(38)	(35)	(25)	(26)	(24)	(38)	(36)	(38)	(22)	(14)	(25)	(18)	(32)	(34)	(33)	(36)	(19)	(9)	2	3	(14)	(27)	(22)	(31)	(47)	(40)	(32)	(29)	(19)	(14)	(26)	(32)	(20)	(17)	(23)	(20)	(16)	(19)	(14)	2	(12)	(7)
Income from Continuing Operations	38	41	40	43	48	53	50	52	71	74	89	116	99	101	100	100	108	115	113	109	77	86	88	82	104	114	113	128	165	162	196	195	230	230	265	290	245	289	297	352	390	400	386	391	404	352	318	336	301	247	228	283	592	918	1 381	1 875	1 785	1 772	1 273	169	(695)	(1 099)	(1 146)	(385)	190	306	(144)	(567)	(1 516)	(1 439)	(716)	(373)	596	708	726	547
Income to Minority Interest	0	0	(1)	(0)	0	(0)	0	(1)	0	(0)	0	0	0	(0)	(0)	0	0	(0)	(0)	(0)	0	0	1	1	4	5	6	6	5	5	5	2	6	6	4	6	1	(0)	0	2	3	3	4	3	3	3	8	10	13	41	58	74	52	32	17	(55)	(65)	(85)	(145)	(119)	(7)	43	121	150	91	51	96	106	153	144	77	80	9	(9)	(60)	(96)
Net Income (Common)	38 N/A	42 +10%	40 -5%	42 +6%	48 +14%	52 +9%	50 -3%	51 +2%	70 +37%	74 +5%	89 +21%	117 +31%	98 -16%	101 +3%	100 -1%	100 0%	107 +7%	115 +7%	113 -2%	109 -4%	77 -29%	86 +12%	89 +3%	83 -6%	108 +30%	119 +10%	119 0%	134 +13%	170 +27%	167 -2%	201 +20%	197 -2%	236 +20%	237 +0%	270 +14%	297 +10%	246 -17%	289 +17%	297 +3%	353 +19%	393 +11%	403 +3%	390 -3%	394 +1%	407 +3%	355 -13%	325 -8%	346 +6%	314 -9%	287 -8%	286 -1%	356 +25%	644 +81%	950 +48%	1 398 +47%	1 820 +30%	1 720 -6%	1 687 -2%	1 128 -33%	50 -96%	(703) N/A	(1 057) -50%	(1 025) +3%	(235) +77%	281 N/A	357 +27%	(48) N/A	(461) -855%	(1 363) -196%	(1 295) +5%	(639) +51%	(293) +54%	605 N/A	699 +16%	667 -5%	451 -32%
EPS (Diluted)	0.06 N/A	0.06 N/A	0.06 N/A	0.06 N/A	0.07 +17%	0.08 +14%	0.08 N/A	0.08 N/A	0.11 +38%	0.11 N/A	0.13 +18%	0.17 +31%	0.14 -18%	0.14 N/A	0.14 N/A	0.13 -7%	0.14 +8%	0.15 +7%	0.14 -7%	0.14 N/A	0.1 -29%	0.11 +10%	0.12 +9%	0.11 -8%	0.14 +27%	0.16 +14%	0.16 N/A	0.17 +6%	0.21 +24%	0.2 -5%	0.23 +15%	0.23 N/A	0.27 +17%	0.26 -4%	0.29 +12%	0.31 +7%	0.27 -13%	0.3 +11%	0.31 +3%	0.37 +19%	0.41 +11%	0.42 +2%	0.41 -2%	0.42 +2%	0.42 N/A	0.38 -10%	0.34 -11%	0.36 +6%	0.33 -8%	0.3 -9%	0.27 -10%	0.36 +33%	0.6 +67%	0.88 +47%	1.29 +47%	1.69 +31%	1.6 -5%	1.57 -2%	1.05 -33%	0.05 -95%	-0.64 N/A	-0.78 -22%	-0.71 +9%	-0.2 +72%	0.21 N/A	0.24 +14%	-0.04 N/A	-0.33 -725%	-1.01 -206%	-0.94 +7%	-0.46 +51%	-0.21 +54%	0.44 N/A	0.51 +16%	0.49 -4%	0.33 -33%

Income Statement Balance Sheet Cash Flow Statement

Tecon Biology Co Ltd
SZSE:002100

Income Statement

Earnings Waterfall
Tecon Biology Co Ltd

Income Statement
Tecon Biology Co Ltd

See Also

Company

Help

Tools

Stocks

Tecon Biology Co Ltd SZSE:002100

Income Statement

Earnings Waterfall Tecon Biology Co Ltd

Income Statement Tecon Biology Co Ltd

See Also

Company

Help

Tools

Stocks

Tecon Biology Co Ltd
SZSE:002100

Earnings Waterfall
Tecon Biology Co Ltd

Income Statement
Tecon Biology Co Ltd